Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains

Journal of Medical Virology

Volumn 57, Issue 3, 1999, Pages 298-307

  MacCormac, Luci P ^a   Grundy, Jane E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cell tropism; CMV; Endothelium; Virus replication

Indexed keywords

BUTYRIC ACID; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOFLUORESCENCE TEST; INOCULATION; NONHUMAN; VIRUS DETECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

CELLS, CULTURED; CYTOMEGALOVIRUS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; VARIATION (GENETICS);

EID: 0032930915     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199903)57:3<298::AID-JMV14>3.0.CO;2-P     Document Type: Article

References (36)

1. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. 1987. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2:291-293.
2. Albrecht T, Boldogh I, Fons M, AbuBakar S, Deng CZ. 1990. Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology 31:68-75.
3. Angulo A, Suto C, Boehm MF, Heyman RA, Ghazal P. 1995. Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol 69:3831-3837.
4. Betts RF. 1982. Cytomegalovirus infection in transplant patients. Prog Med Virol 28:44-64.
5. Brown JM, Kaneshima H, Mocarski ES. 1995. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis 171:1599-1603.
6. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78-83.
7. Einhorn L, Ost A. 1984. Cytomegalovirus infection of human blood cells. J Infect Dis 149:207-214.
8. Foucar E, Mukai K, Foucar K, Sutherland DE, Van-Buren CT. 1981. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 76:788-801.
9. Frazier DP, Cox D, Godshalk EM, Schaffer PA. 1996a. Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for the activation by nerve growth factor and sodium butyrate in PC12 cells. J Virol 70:7433-7444.
10. Frazier DP, Cox D, Godshalk EM, Schaffer PA. 1996b. The herpes simplex type-1 latency associated promoter is activated through ras and raf by nerve growth factor and sodium butyrate in PC12 cells. J Virol 70:7424-7432.
11. Friedman HM, Macarak EJ, MacGregor RR, Wolfe J, Kefalides NA. 1981. Virus infection of endothelial cells. J Infect Dis 143:266-273.
12. Goodman MD, Porter DD. 1973. Cytomegalovirus vasculitis with fatal colonie hemorrhage. Arch Pathol 96:281-284.
13. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
14. Grefte A, van der Giessen M, van Son W, The TH. 1993. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 167:270-277.
15. Grefte JM, van der Giessen M, Blom N, The TH, van Son WJ. 1995. Circulating cytomegalovirus-infected endothelial cells after renal transplantation: possible clue to pathophysiology? Transplant Proc 27:939-942.
16. Grundy JE. 1998. Current antiviral therapy fails to prevent the proinflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack. In: Scholz M, Rabenau HF, Doerr HW, Cinatl JJ, editors. Monographs in virology: CMV-related immunopathology. Basel: Karger, p 67-89.
17. Grundy JE, Lawson K, MacCormac LP, Fletcher JM, Yong KL. 1997. Cytomegalovirus infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177:1465-1474.
18. Ho DD, Rota TR, Andrews CA, Hirsch MS. 1984. Replication of human cytomegalovirus in endothelial cells. J Infect Dis 150:956-957.
19. Ho M. 1977. Virus infections after transplantation in man. Brief review. Arch Virol 55:1-24.
20. Ho WZ, Cherukuri R, Ge SD, Cutilli JR, Song L, Whitko S, Douglas SD. 1993. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro. J Leukocyte Biol 53:208-212.
21. Hodgkin PD, Scalzo AA, Swaminathan N, Price P, Shellam GR. 1988. Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods 22:215-230.
22. Jacobson MA, Mills J. 1988. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med 108:585-594.
23. Lafemina RL, Hayward GS. 1988. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol 69:355-374.
24. Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R. 1990. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 9: 707-711.
25. MacCormac LP, Grundy JE. 1996. Human cytomegalovirus induces an Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc gammaRs. J Infect Dis 174:1151-1161.
26. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. 1989. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 64:359-362.
27. Percivalle E, Revello MG, Vago L, Morini F, Gerna G. 1993. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 92:663-670.
28. Quinnan GVJ, Delery M, Rook AH, Frederick WR, Epstein JS, Manischewitz JF, Jackson L, Ramsey KM, Mittal K, Plotkin SA, et-al. 1984. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med 101:478-483.
29. Radsak K, Fuhrmann R, Franke RP, Schneider D, Kollert A, Brucher KH, Drenckhahn D. 1989. Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Arch Virol 107:151-158.
30. Roy DM, Grundy JE. 1992. Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations. Transplantation 54:1109-1110.
31. Smiley ML, Mar EC, Huang ES. 1988. Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol 25:213-226.
32. Sonnabend J, Witkin SS, Purtilo DT. 1983. Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. JAMA 249:2370-2374.
33. Waldman WJ, Knight DA, Huang EH, Sedmak DD. 1995. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 171:263-272.
34. Waldman WJ, Sneddon JM, Stephens RE, Roberts WH. 1989. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol 28:223-230.
35. Weller TH. 1971. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med 285:203-214.
36. Wu QH, Ascensao J, Almeida G, Forman SJ, Shanley JD. 1994. The effect of short-chain fatty acids on the susceptibility of human umbilical vein endothelial cells to human cytomegalovirus infection. J Virol Methods 47:37-50.